According to IMARC Group’s latest report, titled “China Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the China genetic testing market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028.

Genetic testing is used to examine changes in chromosome structure or deoxyribonucleic acid (DNA) sequence that can cause the risk of a genetic disorder. The test is carried out using blood, urine, saliva, body tissue, bone, or hair samples. The results can help identify the patient’s chance of developing or passing a genetic disorder to offspring. The testing also enables the early diagnosis of chronic diseases, which helps in ensuring timely treatment and prevention. In China, genetic testing is witnessing wide-ranging applications in medicine for determining genetic lineage and the probability of developing and passing on the disorder, diagnosing genetic conditions, and identifying the most effective drugs based on the genetic profile.

Request for a PDF Sample of this Report: https://www.imarcgroup.com/china-genetic-testing-market/requestsample

China Genetic testing Market Trends:

The availability of direct-to-consumer (DTC) tests and the inflating consumer expenditure power are some of the factors primarily driving the market growth in China. Moreover, the rising cases of genetic disorders and the increasing consumer awareness regarding genetic testing and its benefits are providing a significant boost to the market growth. Additionally, the recent COVID-19 pandemic has surged the adoption of home testing kits and virtual testing for sample collection purposes, which, in turn, is boosting the market growth. Furthermore, significant investments in research and development (RD) activities and the implementation of the two-child policy by the Government of the People’s Republic of China are creating a positive outlook for the market in the country. Apart from this, the burgeoning middle-class population, rapidly expanding healthcare sector, and rising geriatric population are positively contributing to the market growth.

China Genetic testing Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the China genetic testing market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• BGI
• Berry Genomics Co. ltd.
• Daan Gene Co. Ltd
• WuXi NextCODE
• Annoroad Gene Technology Co. Ltd.
• WuXi PharmaTech

Key Market Segmentation:

The report has segmented the China genetic testing market on the basis of test type, disease, technology, service provider and testing sample.

Breakup by Test Type:

• Prenatal Testing
• Carrier Testing
• New Born Testing
• Predictive/Presymptomatic Testing
• Diagnostic Testing
• Others

Breakup by Disease:

• Cancer
• Down Syndrome
• Thalassemia
• Others

Breakup by Technology:

• Biochemical
• Molecular
• Cytogenetic

Breakup by Service Provider:

• Hospital Based Laboratories
• Independent Laboratories
• Specialty Clinics

Breakup by Testing Sample:

• Blood
• Saliva
• Hair
• Others

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=reportid=1111flag=F

Key Highlights of the Report:                                                           

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                                                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800